J. Leighton Read serves as Executive at Alexza Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, J. Leighton Read has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 21, 2016 involved transacting 3,492 shares valued at $0.
J. Leighton Read currently holds 34,922 shares of Alexza Pharmaceuticals Inc. (ALXA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, J. Leighton Read has been a net neutral trader of ALXA stock. They have purchased $0 and sold $0 worth of shares.
J. Leighton Read's most recent insider trade was on Jun 21, 2016, when they sold 3,492 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 22, 2009 | ALXA | $0 | Award | 16,014 | $N/A | Discretionary |
| Mar 13, 2006 | ALXA | $0 | Conversion | 35,594 | $N/A | Discretionary |
| Mar 13, 2006 | ALXA | $0 | Conversion | 1,318,356 | $N/A | Discretionary |